 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol IDs
|
|
|
| |
Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer
|
|
|
|
Phase III, Phase II
|
|
|
|
WHC-MRI-GU-2006-097
NCT00397761
|
|
| |
Comparing RadiaPlexRx Hydrogel and Standard-of-Care for Radiation Dermatitis in Breast Cancer Patients
|
|
|
|
Phase III
|
|
|
|
2006-0827
NCT00481884
|
|
| |
Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer
|
|
|
|
Phase II
|
|
|
|
CHNMC-05042
NCT00182793
|
|
| |
Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer
|
|
|
|
Phase II
|
|
|
|
0903-882
0309006307, NCT00195091
|
|
| |
Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer
|
|
|
|
Phase II
|
|
|
|
CHNMC-05015
NCT00295893
|
|
| |
Oxidized Glutathione (NOV-002), Doxorubicin, Cyclophosphamide, and Docetaxel in Treating Women With Newly Diagnosed Stage IIB, or Stage IIIC Breast Cancer
|
|
|
|
Phase II
|
|
|
|
MUSC-101072
MUSC-HR-17111, 101072, NCT00499122
|
|
| |
Sunitinib and Combination Chemotherapy Before Surgery in Treating Patients With Stage II or Stage III Breast Cancer
|
|
|
|
Phase II
|
|
|
|
UWCC-6488
6488, UWCC-UW-6488, UWCC-07-6437-H/A, NCT00513695
|
|
| |
Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer
|
|
|
|
Phase II
|
|
|
|
F061229006
UAB 0648, NCT00530868
|
|
| |
Phase II Trial of Neoadjuvant Metronomic Chemotherapy in Triple-Negative Breast Cancer
|
|
|
|
Phase II
|
|
|
|
LJCC 07-03
NCT00542191
|
|
| |
Phase II Neoadjuvant in Inflammatory Breast Cancer
|
|
|
|
Phase II
|
|
|
|
2007-0818
NCT00756470
|
|
